Biote Announces Participation in the Jefferies Healthcare Conference 2022

IRVING, Texas--()--biote Corp. (“Biote” or the “Company”) (Nasdaq: BTMD), a high growth, differentiated medical practice-building business within the hormone optimization space, today announces that Terry Weber, Biote’s Chief Executive Officer, is scheduled to present at the Jefferies 2022 Healthcare Conference in New York City on Wednesday, June 8, 2022 at 1:30 p.m. Eastern Time. A live webcast of the presentation will be available here. A replay of the available webcast will be accessible for 90 days following the live event.

Terry Weber and Marc Beer, Biote’s Chairman, will also be participating in investor meetings throughout the conference.

About Biote

Biote is a woman-led company operating a high growth, differentiated medical practice-building business within the hormone optimization space. Biote trains practitioners how to identify and treat early indicators of hormone-related aging conditions. Biote went public on Nasdaq on May 27, 2022. To learn more about Biote, please visit www.biote.com.

Contacts

Media
Karen Chase
Karen.Chase@westwicke.com

Investors
Mike Cavanaugh
Mike.Cavanaugh@westwicke.com

Release Summary

Biote Announces Participation in the Jefferies Healthcare Conference 2022

Contacts

Media
Karen Chase
Karen.Chase@westwicke.com

Investors
Mike Cavanaugh
Mike.Cavanaugh@westwicke.com